Ociimum Trading & Investments Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 5.00 M
as on 08-07-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2015)
- Profit 1800.20%
(FY 2015)
- Ebitda -8577.38%
(FY 2015)
- Net Worth 33.56%
(FY 2015)
- Total Assets -10.64%
(FY 2015)
About Ociimum Trading & Investments
The Corporate was formerly known as Ociimum Research And Technology Private Limited. The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Lekhaben Maheshwari, Girish Maheshwari, and Amit Maheshwari serve as directors at the Company.
- CIN/LLPIN
U65100GJ2011PTC066768
- Company No.
066768
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2011
- Date of AGM
15 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ociimum Trading & Investments?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lekhaben Maheshwari  | Director | 16-Aug-2011 | Current |
| Girish Maheshwari | Director | 16-Aug-2011 | Current |
| Amit Maheshwari | Director | 16-Aug-2011 | Current |
Financial Performance of Ociimum Trading & Investments.
Ociimum Trading & Investments Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1800.2% increase in profit. The company's net worth Soared by an impressive increase of 33.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ociimum Trading & Investments?
In 2017, Ociimum Trading & Investments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aaria Bio - Lifesciences Research Private LimitedActive 14 years 3 monthsAmit Maheshwari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ociimum Trading & Investments?
Unlock and access historical data on people associated with Ociimum Trading & Investments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ociimum Trading & Investments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ociimum Trading & Investments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
